本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

16.48
-0.7400-4.30%
盤後:16.500.0200+0.12%19:31 EST
成交量:301.02萬
成交額:5,001.91萬
市值:16.80億
市盈率:-3.18
高:17.35
開:16.94
低:16.43
收:17.22
52周最高:39.89
52周最低:12.73
股本:1.02億
流通股本:7,773.53萬
量比:0.72
換手率:3.87%
股息:- -
股息率:- -
每股收益(TTM):-5.1758
每股收益(LYR):-5.8316
淨資產收益率:-608.47%
總資產收益率:-22.98%
市淨率:-4.47
市盈率(LYR):-2.83

資料載入中...

2026/11/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/04

重要事件披露

Form 8-K - Current report
2026/10/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/10/20

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/19

重要事件披露

Form 8-K - Current report
2026/10/14

重要事件披露

Form 8-K - Current report
2026/10/07

重要事件披露

Form 8-K - Current report
2026/09/17

重要事件披露

Form 8-K - Current report
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities